Free Trial

Panbela Therapeutics (PBLA) Short Interest Ratio & Short Volume

Panbela Therapeutics logo
$0.28 -0.02 (-5.30%)
As of 06/4/2025 12:36 PM Eastern

Panbela Therapeutics Short Interest Data

Panbela Therapeutics (PBLA) has a short interest of 100 shares. This marks a -93.75% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.0, indicating that it would take 0.0 days of the average trading volume of 18,811 shares to cover all short positions.

Current Short Interest
100 shares
Previous Short Interest
1,600 shares
Change Vs. Previous Month
-93.75%
Dollar Volume Sold Short
$30.00
Short Interest Ratio
0.0 Days to Cover
Last Record Date
May 15, 2025
Outstanding Shares
4,855,000 shares
Percentage of Shares Shorted
0.00%
Today's Trading Volume
8,762 shares
Average Trading Volume
18,811 shares
Today's Volume Vs. Average
47%
Short Selling Panbela Therapeutics?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Panbela Therapeutics and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

PBLA Short Interest Over Time

PBLA Days to Cover Over Time

PBLA Percentage of Float Shorted Over Time

Panbela Therapeutics Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
5/15/2025100 shares $30.00 -93.8%N/A0 $0.30
4/30/20251,600 shares $424.00 No ChangeN/A0.1 $0.27
4/15/2025100 shares $31.30 -66.7%N/A0 $0.31
3/14/2025300 shares $111.30 -95.5%N/A0 $0.37
2/14/2025300 shares $102.00 -25.0%N/A0 $0.34
1/31/2025400 shares $140.00 -94.0%N/A0 $0.35
1/15/20256,700 shares $2,814.00 +6,600.0%N/A0.1 $0.42
2/29/2024114,700 shares $135,346.00 +7.2%2.4%0.1 $1.18
2/15/2024107,000 shares $135,890.00 -39.8%2.2%0.1 $1.27
1/31/2024177,700 shares $247,003.00 +283.0%3.7%0.3 $1.39
1/15/202446,400 shares $584,640.00 -96.6%9.7%0.2 $12.60
12/31/20231,350,000 shares $1.24 million +1,319.6%14.1%0.3 $0.92
12/15/202395,100 shares $43,470.21 +115.7%1.9%0 $0.46
11/30/202344,100 shares $23,373.00 -32.1%0.9%0 $0.53
11/15/202364,900 shares $39,134.70 -22.2%1.3%0.1 $0.60
10/31/202383,400 shares $66,903.48 +22.5%2.8%0.1 $0.80
10/15/202368,100 shares $70,143.00 -21.5%2.3%0.6 $1.03
9/30/202386,700 shares $113,577.00 -18.2%3.0%0.1 $1.31
9/15/2023106,000 shares $139,920.00 +26.6%3.6%0.1 $1.32
8/31/202383,700 shares $116,343.00 +335.9%2.9%0.1 $1.39
8/15/202319,200 shares $28,800.00 -60.5%0.7%0 $1.50
7/31/202348,600 shares $97,686.00 +102.5%1.7%0.1 $2.01
7/15/202324,000 shares $49,920.00 -74.6%0.9%0 $2.08
6/30/202394,600 shares $217,580.00 -50.3%3.4%0.4 $2.30
6/15/2023190,500 shares $1.11 million +590.2%6.9%0.9 $5.81
5/31/202327,600 shares $186,382.80 -96.3%5.1%0.2 $6.75
5/15/2023754,400 shares $309,304.00 -59.9%N/A0.3 $0.41
4/30/20231,880,000 shares $1.03 million -23.0%N/A0.6 $0.55
4/15/20232,440,000 shares $1.39 million +611.6%N/A0.9 $0.57
3/31/2023342,900 shares $151,630.38 +3.9%N/A0.1 $0.44
3/15/2023330,200 shares $219,549.98 -61.6%N/A0.2 $0.66
2/28/2023859,300 shares $1.18 million -18.2%13.7%0.5 $1.37
2/15/20231,050,000 shares $1.52 million +596.8%16.7%0.7 $1.45
1/31/2023150,700 shares $247,148.00 -63.9%2.5%0.1 $1.64
1/15/2023417,700 shares $1.39 million -67.4%55.4%1.2 $3.32
12/30/20221,280,000 shares $93,824.00 +60.5%N/A0.2 $0.07
12/15/2022797,500 shares $77,357.50 +227.1%N/A0.2 $0.10
11/30/2022243,800 shares $33,010.52 +354.9%N/A0.2 $0.14
11/15/202253,600 shares $8,522.40 +51.8%N/A0.1 $0.16
10/31/202235,300 shares $4,465.45 -23.9%N/A0 $0.13
The Real Reason Silver Prices Are Soaring (Ad)

Elon Musk is back in the spotlight—this time for fueling a global scramble for silver. Tesla's relentless production of electric vehicles and solar technology is driving demand for the precious metal to unprecedented levels. Silver—critical for EV batteries, solar panels, and advanced electronics—is now at the center of a supply crisis.

I'm offering a new 2025 Silver Wealth Guide and it is now available.
10/15/202246,400 shares $10,347.20 -95.6%N/A0.1 $0.22
9/30/20221,050,000 shares $283,815.00 +276.9%N/A1.7 $0.27
9/15/2022278,600 shares $105,589.40 +101.0%N/A0.5 $0.38
8/31/2022138,600 shares $95,744.88 +9.4%N/A2.4 $0.69
8/15/2022126,700 shares $150,773.00 -24.0%N/A2.7 $1.19
7/31/2022166,700 shares $206,708.00 -4.9%N/A3.7 $1.24
7/15/2022175,300 shares $194,583.00 +19.7%N/A3.9 $1.11
6/30/2022146,400 shares $96,638.64 -4.6%N/A3.1 $0.66
6/15/2022153,500 shares $193,410.00 +1.2%N/A4.4 $1.26
5/31/2022151,700 shares $227,550.00 +31.0%N/A8.6 $1.50
5/15/2022115,800 shares $185,534.76 -18.6%N/A4.1 $1.60
4/30/2022142,200 shares $251,694.00 -14.3%N/A4.3 $1.77
4/15/2022165,900 shares $328,482.00 +3.3%N/A4.5 $1.98
3/31/2022160,600 shares $338,866.00 +9.9%N/A4.3 $2.11
3/15/2022146,200 shares $248,540.00 -15.3%N/A3.2 $1.70
2/28/2022172,600 shares $336,570.00 +21.8%N/A3.3 $1.95
2/15/2022141,700 shares $317,408.00 -18.1%N/A2.4 $2.24
1/31/2022173,100 shares $368,703.00 -6.2%N/A3.1 $2.13
1/15/2022184,600 shares $304,590.00 -17.7%N/A3.3 $1.65
12/31/2021224,200 shares $387,888.42 +18.9%N/A4.1 $1.73
12/15/2021188,600 shares $330,050.00 -10.6%N/A3.7 $1.75
11/30/2021211,000 shares $390,350.00 +5.3%N/A4.1 $1.85
11/15/2021200,300 shares $426,639.00 -0.7%N/A3.5 $2.13
10/29/2021201,800 shares $431,852.00 -1.5%N/A3.6 $2.14
10/15/2021204,900 shares $405,702.00 +5.2%N/A1.6 $1.98
9/30/2021194,800 shares $422,716.00 -9.4%N/A1.3 $2.17
9/15/2021214,900 shares $472,780.00 -2.5%N/A0.9 $2.20
8/31/2021220,500 shares $500,535.00 -14.7%N/A0.9 $2.27
8/13/2021258,400 shares $607,240.00 +5.7%N/A1.1 $2.35
7/30/2021244,400 shares $615,888.00 +12.5%N/A1 $2.52
7/15/2021217,200 shares $562,548.00 -35.5%N/A1.3 $2.59
6/30/2021336,500 shares $952,295.00 +85.2%N/A2.1 $2.83
6/15/2021181,700 shares $675,924.00 -6.2%2.2%2.7 $3.72
5/28/2021193,800 shares $813,960.00 +6.9%2.3%3 $4.20
5/14/2021181,300 shares $692,566.00 -14.0%2.2%3.2 $3.82
4/30/2021210,900 shares $982,794.00 +18.2%2.5%1.8 $4.66
4/15/2021178,400 shares $713,600.00 -5.2%2.1%1.1 $4.00
3/31/2021188,100 shares $769,329.00 -3.9%2.3%1.2 $4.09
3/15/2021195,700 shares $884,564.00 +16.6%2.4%1.2 $4.52
2/26/2021167,800 shares $739,998.00 -12.2%2.2%0.8 $4.41
2/12/2021191,000 shares $1.03 million +38.3%2.5%1 $5.38
1/29/2021138,100 shares $760,240.50 +78.9%1.8%0.9 $5.51
1/15/202177,200 shares $633,040.00 No Change1.0%0.8 $8.20

PBLA Short Interest - Frequently Asked Questions

What is Panbela Therapeutics' current short interest?

Short interest is the volume of Panbela Therapeutics shares that have been sold short but have not yet been covered or closed out. As of May 15th, traders have sold 100 shares of PBLA short. Learn More on Panbela Therapeutics' current short interest.

Is Panbela Therapeutics' short interest increasing or decreasing?

Panbela Therapeutics saw a decline in short interest in May. As of May 15th, there was short interest totaling 100 shares, a decline of 93.8% from the previous total of 1,600 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Panbela Therapeutics' short interest compare to its competitors?

Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Panbela Therapeutics: Alaunos Therapeutics, Inc. (4.39%), CERo Therapeutics Holdings, Inc. (11.96%), Titan Pharmaceuticals, Inc. (1.27%), IM Cannabis Corp. (0.87%), Mustang Bio, Inc. (1.87%), Galecto, Inc. (4.86%), Clearmind Medicine Inc. (5.50%), PainReform Ltd. (12.29%), Palisade Bio, Inc. (3.68%), Lixte Biotechnology Holdings, Inc. (1.57%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($29.20 billion), Strategy Incorporated ($10.88 billion), iShares 20+ Year Treasury Bond ETF ($10.04 billion), Capital One Financial Co. ($5.51 billion), Charter Communications, Inc. ($5.00 billion), Super Micro Computer, Inc. ($4.43 billion), Apollo Global Management, Inc. ($4.02 billion), Hims & Hers Health, Inc. ($3.65 billion), VanEck Semiconductor ETF ($3.27 billion), and Coinbase Global, Inc. ($3.10 billion). View all of the most shorted stocks.

What does it mean to sell short Panbela Therapeutics stock?

Short selling PBLA is an investing strategy that aims to generate trading profit from Panbela Therapeutics as its price is falling. PBLA shares are trading down $0.02 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Panbela Therapeutics?

A short squeeze for Panbela Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of PBLA, which in turn drives the price of the stock up even further.

How often is Panbela Therapeutics' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including PBLA, twice per month. The most recent reporting period available is May, 15 2025.




This page (NASDAQ:PBLA) was last updated on 6/5/2025 by MarketBeat.com Staff
From Our Partners